tiprankstipranks
Entera Bio Announces Key Regulatory Milestone for Oral PTH(1-34) Peptide (EB613) Phase 3 Program: FDA Ruling on Qualifying BMD as a Surrogate Endpoint for Osteoporosis Drugs is Expected Within 10 Months
PremiumPress ReleasesEntera Bio Announces Key Regulatory Milestone for Oral PTH(1-34) Peptide (EB613) Phase 3 Program: FDA Ruling on Qualifying BMD as a Surrogate Endpoint for Osteoporosis Drugs is Expected Within 10 Months
1M ago
Entera Bio announces PK data from oral GLP-2 peptide tablet treatment
PremiumThe Fly
Entera Bio announces PK data from oral GLP-2 peptide tablet treatment
1M ago
Entera Bio management to meet virtually with Oppenheimer
PremiumThe Fly
Entera Bio management to meet virtually with Oppenheimer
1M ago
Entera Bio Announces Full Year 2023 Financial Results and Provides Business Updates
PremiumPress ReleasesEntera Bio Announces Full Year 2023 Financial Results and Provides Business Updates
2M ago
Entera Bio management to meet with Oppenheimer
PremiumThe Fly
Entera Bio management to meet with Oppenheimer
2M ago
Entera Bio management to meet with Oppenheimer
PremiumThe Fly
Entera Bio management to meet with Oppenheimer
2M ago
Entera Bio Ltd. Files SEC Registration for Private Placement
PremiumCompany AnnouncementsEntera Bio Ltd. Files SEC Registration for Private Placement
3M ago
Entera Bio files to sell 16.5M ordinary shares for holders
PremiumThe Fly
Entera Bio files to sell 16.5M ordinary shares for holders
3M ago
Entera Bio to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference
PremiumPress Releases
Entera Bio to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100